Clinical presentation and prognosis in MOG-antibody disease: a UK study
<p>A condition associated with an autoantibody against myelin oligodendrocyte glycoprotein has been recently recognized as a new inflammatory disease of the central nervous system, but the disease course and disability outcomes are largely unknown. In this study we investigated clinical charac...
| Päätekijät: | , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Oxford University Press
2017
|